A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia
Clinical trial NCT07313852 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07313852
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2029-01-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.